We are live on ! Find out more
UONDDL

University of Notre Dame du Lac Portfolio holdings

AUM $66.8M
1-Year Est. Return 43.52%
This Fund
S&P 500
This Quarter Est. Return
+5.92%
1 Year Est. Return
+43.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$538M
AUM Growth
+$21.3M
Cap. Flow
-$1.29M
Cap. Flow %
-0.24%
Top 10 Hldgs %
32.48%
Holding
83
New
16
Increased
21
Reduced
28
Closed
15

Sector Composition

Rank Sector Weight
1 Technology 18.01%
2 Healthcare 13.48%
3 Consumer Discretionary 12.03%
4 Financials 11.03%
5 Industrials 10.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATRA icon
51
Atara Biotherapeutics
ATRA
$83.1M
$2.98M 0.55%
2,888
-7,109
-71% -$6.95M
ONC
52
BeOne Medicines Ltd
ONC
$40.6B
$2.92M 0.54%
16,946
+2,246
+15% +$378K
WMGI
53
DELISTED
Wright Medical Group Inc
WMGI
$2.91M 0.54%
100,225
-15,033
-13% -$405K
ASND icon
54
Ascendis Pharma A/S
ASND
$16.8B
$2.9M 0.54%
40,871
-1,309
-3% -$90.1K
INCY icon
55
Incyte
INCY
$24.5B
$2.89M 0.54%
41,824
-39,952
-49% -$2.74M
EPZM
56
DELISTED
Epizyme, Inc
EPZM
$2.89M 0.54%
272,476
+98,494
+57% +$1.12M
UTHR icon
57
United Therapeutics
UTHR
$21.9B
$2.88M 0.54%
22,538
-3,140
-12% -$388K
SGEN
58
DELISTED
Seagen Inc. Common Stock
SGEN
$2.87M 0.53%
37,240
-10,734
-22% -$791K
HUM icon
59
Humana
HUM
$46.7B
$2.86M 0.53%
8,438
-1,027
-11% -$334K
INSM icon
60
Insmed
INSM
$28.9B
$2.67M 0.5%
132,220
+31,157
+31% +$704K
LH icon
61
Labcorp
LH
$26.2B
$2.67M 0.5%
17,913
-58,030
-76% -$8.83M
SAGE
62
DELISTED
Sage Therapeutics
SAGE
$2.61M 0.49%
18,507
+2,684
+17% +$414K
ALNY icon
63
Alnylam Pharmaceuticals
ALNY
$30B
$2.61M 0.49%
29,826
+2,874
+11% +$289K
IMMU
64
DELISTED
Immunomedics Inc
IMMU
$2.58M 0.48%
123,687
-22,687
-15% -$537K
MDGL icon
65
Madrigal Pharmaceuticals
MDGL
$12.4B
$2.51M 0.47%
+11,732
New +$2.94M
CLVS
66
DELISTED
Clovis Oncology, Inc.
CLVS
$2.36M 0.44%
80,441
+26,244
+48% +$1.02M
MRTX
67
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.24M 0.42%
+47,630
New +$2.65M
VNQ icon
68
Vanguard Real Estate ETF
VNQ
$38.6B
$1.34M 0.25%
16,587
+234
+1% +$19.3K
ADBE icon
69
Adobe
ADBE
$103B
-36,867
Closed -$8.99M
ASIX icon
70
AdvanSix
ASIX
$427M
-232,487
Closed -$8.52M
DBVT
71
DBV Technologies
DBVT
$889M
-11,156
Closed -$2.15M
DE icon
72
Deere & Co
DE
$167B
-59,939
Closed -$8.38M
IT icon
73
Gartner
IT
$11.3B
-64,533
Closed -$8.58M
JD icon
74
JD.com
JD
$42.7B
-684,152
Closed -$26.6M
NGNE icon
75
Neurogene
NGNE
$738M
-10,738
Closed -$569K

Similar funds

University of Notre Dame du Lac's Q3 2018 Portfolio in Review

As of Q3 2018, University of Notre Dame du Lac held 83 positions worth $538M, up 4.1% from $517M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

University of Notre Dame du Lac's Q3 2018 filing shows 16 new, 21 increased, 28 reduced and 15 closed positions. Its largest new stake was Alibaba: 166,990 shares worth $27.5M. The largest sale was JD.com, an estimated $26.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • University of Notre Dame du Lac's largest Q3 2018 buy was Alibaba: 166,990 shares worth $27.5M.
  • University of Notre Dame du Lac added most to Meta Platforms (Facebook) in Q3 2018, an estimated $9.62M increase.
  • University of Notre Dame du Lac's biggest Q3 2018 reduction was Charter Communications, cutting an estimated $10.7M.
  • University of Notre Dame du Lac fully exited JD.com in Q3 2018, selling an estimated $26.6M.
  • University of Notre Dame du Lac's ten largest holdings make up 32% of its $538M portfolio in Q3 2018.
  • University of Notre Dame du Lac opened 16 new positions and closed 15 in Q3 2018.
  • University of Notre Dame du Lac's portfolio value rose 4.1% quarter-over-quarter to $538M.

Based on University of Notre Dame du Lac's 13F filing for Q3 2018, filed 13 Nov 2018.